Two Sigma Advisers’s AngioDynamics ANGO Stock Holding History

Two Sigma Advisers’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-230,001	Closed	-$2.95M	–	129
2025 Q4	$2.95M	Buy	230,001 +153,501	+201%	+$1.89M	0.01%	1032
2025 Q3	$855K	Buy	76,500 +62,500	+446%	+$603K	﹤0.01%	1539
2025 Q2	$139K	Sell	14,000 -20,100	-59%	-$197K	﹤0.01%	2171
2025 Q1	$320K	Sell	34,100 -226,600	-87%	-$2.38M	﹤0.01%	1964
2024 Q4	$2.39M	Sell	260,700 -121,500	-32%	-$893K	0.01%	1035
2024 Q3	$2.97M	Sell	382,200 -186,500	-33%	-$1.35M	0.01%	898
2024 Q2	$3.44M	Sell	568,700 -109,300	-16%	-$674K	0.01%	926
2024 Q1	$3.98M	Sell	678,000 -12,100	-2%	-$71.9K	0.01%	868
2023 Q4	$5.41M	Sell	690,100 -90,300	-12%	-$626K	0.01%	770
2023 Q3	$5.7M	Buy	780,400 +476,500	+157%	+$3.96M	0.01%	668
2023 Q2	$3.17M	Buy	303,900 +35,200	+13%	+$339K	0.01%	966
2023 Q1	$2.78M	Buy	268,700 +14,200	+6%	+$182K	0.01%	1089
2022 Q4	$3.5M	Buy	254,500 +208,000	+447%	+$2.89M	0.01%	933
2022 Q3	$951K	Buy	+46,500	New	+$1.02M	﹤0.01%	1542
2022 Q2	–	Sell	-14,000	Closed	-$302K	–	2640
2022 Q1	$302K	Sell	14,000 -11,100	-44%	-$252K	﹤0.01%	2218
2021 Q4	$692K	Sell	25,100 -11,671	-32%	-$322K	﹤0.01%	1749
2021 Q3	$954K	Sell	36,771 -22,700	-38%	-$607K	﹤0.01%	1643
2021 Q2	$1.61M	Sell	59,471 -57,500	-49%	-$1.4M	﹤0.01%	1409
2021 Q1	$2.74M	Sell	116,971 -11,100	-9%	-$224K	0.01%	1119
2020 Q4	$1.96M	Sell	128,071 -86,500	-40%	-$1.1M	0.01%	1271
2020 Q3	$2.59M	Buy	214,571 +39,000	+22%	+$370K	0.01%	1033
2020 Q2	$1.79M	Buy	175,571 +3,000	+2%	+$30.9K	0.01%	1258
2020 Q1	$1.8M	Buy	172,571 +45,200	+35%	+$567K	0.01%	1170
2019 Q4	$2.04M	Buy	127,371 +74,600	+141%	+$1.14M	﹤0.01%	1219
2019 Q3	$972K	Buy	52,771 +2,100	+4%	+$41.1K	﹤0.01%	1450
2019 Q2	$998K	Sell	50,671 -807	-2%	-$16.4K	﹤0.01%	1521
2019 Q1	$1.18M	Sell	51,478 -56,800	-52%	-$1.23M	﹤0.01%	1449
2018 Q4	$2.18M	Sell	108,278 -54,223	-33%	-$1.12M	0.01%	1140
2018 Q3	$3.53M	Sell	162,501 -23,500	-13%	-$522K	0.01%	969
2018 Q2	$4.14M	Buy	186,001 +12,100	+7%	+$247K	0.01%	927
2018 Q1	$3M	Sell	173,901 -31,788	-15%	-$530K	0.01%	1061
2017 Q4	$3.42M	Sell	205,689 -44,512	-18%	-$760K	0.01%	994
2017 Q3	$4.28M	Buy	250,201 +22,500	+10%	+$378K	0.01%	862
2017 Q2	$3.69M	Buy	227,701 +36,500	+19%	+$577K	0.01%	894
2017 Q1	$3.32M	Sell	191,201 -32,171	-14%	-$538K	0.01%	1001
2016 Q4	$3.77M	Buy	223,372 +92,180	+70%	+$1.54M	0.01%	863
2016 Q3	$2.3M	Buy	131,192 +49,700	+61%	+$806K	0.01%	971
2016 Q2	$1.17M	Buy	81,492 +6,100	+8%	+$76.2K	0.01%	1093
2016 Q1	$927K	Sell	75,392 -64,200	-46%	-$709K	0.01%	1157
2015 Q4	$1.7M	Buy	139,592 +44,398	+47%	+$547K	0.01%	803
2015 Q3	$1.28M	Buy	95,194 +1,701	+2%	+$25.7K	0.01%	908
2015 Q2	$1.53M	Sell	93,493 -30,799	-25%	-$511K	0.01%	916
2015 Q1	$2.21M	Buy	124,292 +18,000	+17%	+$335K	0.02%	726
2014 Q4	$2.02M	Buy	106,292 +38,700	+57%	+$656K	0.02%	826
2014 Q3	$927K	Sell	67,592 -15,300	-18%	-$218K	0.01%	1170
2014 Q2	$1.35M	Buy	82,892 +700	+0.9%	+$10.1K	0.01%	1009
2014 Q1	$1.29M	Buy	82,192 +8,100	+11%	+$132K	0.01%	999
2013 Q4	$1.27M	Buy	74,092 +44,400	+150%	+$683K	0.01%	1003
2013 Q3	$392K	Buy	29,692 +11,100	+60%	+$131K	﹤0.01%	1525
2013 Q2	$211K	Buy	+18,592	New	+$198K	﹤0.01%	1939

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.5M AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

WCM

Weber Capital Management San Francisco, California $100M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAM

Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Two Sigma Advisers's ANGO Position: Q1 2026 in Review

Two Sigma Advisers sold out of AngioDynamics (ANGO) in Q1 2026, closing a stake of 230,001 shares — an estimated $2.95M sold.

Two Sigma Advisers first reported a position in ANGO in Q2 2013 and held it in 50 quarters. The position peaked at $5.7M in Q3 2023. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

Two Sigma Advisers reported no remaining AngioDynamics position as of Q1 2026 after selling out during the quarter.
Two Sigma Advisers sold 230,001 AngioDynamics shares in Q1 2026, an estimated $2.95M.
Two Sigma Advisers first reported a position in AngioDynamics in Q2 2013 and held it in 50 quarters.
Two Sigma Advisers's AngioDynamics position peaked at $5.7M in Q3 2023.
147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.